Comparison Of Different Doses Of Intrathecal Neostigmine In Prevention Of Post-Dural Puncture Headache
Clinical trial NCT04905953 · UNKNOWN
Trial details
- NCT number
- NCT04905953
- Sponsor
- Cairo University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2022-02-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.